Indoleamine 2,3-dioxygenase–expressing antigen-presenting cells and peripheral T-cell tolerance: Another piece to the atopic puzzle?
- 30 November 2003
- journal article
- review article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 112 (5), 854-860
- https://doi.org/10.1016/s0091-6749(03)02014-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tolerance, DCs and tryptophan: much ado about IDOTrends in Immunology, 2003
- Unraveling the mission of FcϵRI on antigen-presenting cellsJournal of Allergy and Clinical Immunology, 2003
- Atopic dermatitisThe Lancet, 2003
- CTLA-4–Ig regulates tryptophan catabolism in vivoNature Immunology, 2002
- Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-DioxygenaseScience, 2002
- Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-DioxygenaseThe Journal of Experimental Medicine, 2002
- Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic CellsThe Journal of Experimental Medicine, 2002
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999
- The Emerging Role of CTLA-4 as an Immune AttenuatorImmunity, 1997
- Importance of the Two Interferon-stimulated Response Element (ISRE) Sequences in the Regulation of the Human Indoleamine 2,3-Dioxygenase GeneJournal of Biological Chemistry, 1996